The PVAT–MAMs Axis in Atherosclerosis: A Hypothesis-Driven Cross-Scale Conceptual Framework
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27072998 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Sixiang Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250013, China. Hauptthemen laut MEDLINE: Atherosclerosis, Adipose Tissue, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 248 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Noncommunicable Chronic Diseases-National Science and Technology Major Project of China, The Natural Science Foundation of Shandong Province, Noncommunicable Chronic Diseases–National Science and Technology Major Project of the People’s Republic of China.
Abstract (Originalsprache)
Atherosclerosis (AS) is the leading cause of cardiovascular disease worldwide, yet its clinical heterogeneity and close association with metabolic disorders are not fully explained by the classical “endothelial injury–lipid deposition–inflammatory amplification” paradigm. In this review, we introduce the PVAT–MAMs axis as a hypothesis-driven, cross-scale conceptual framework linking extravascular metabolic dysfunction to intracellular stress signaling in vascular cells. We propose that, under metabolic stress, dysfunctional perivascular adipose tissue (PVAT) may influence mitochondria-associated endoplasmic reticulum membranes (MAMs) via the release of inflammatory, lipotoxic, and oxidative mediators. Accumulating experimental and associative evidence suggests that perturbation of MAMs is associated with dysregulated calcium handling, lipid metabolism, inflammatory signaling, and redox imbalance, processes implicated in AS progression. Although direct causal relationships remain to be fully established. By synthesizing current findings, this framework provides an integrative perspective on disease heterogeneity and highlights testable pathogenic nodes spanning from PVAT to subcellular MAMs. Finally, we discuss how this conceptual axis may inform hypothesis-driven therapeutic strategies. Importantly, the PVAT–MAMs axis is presented as a hypothesis-driven conceptual model rather than an established signaling pathway, and its mechanistic architecture requires rigorous experimental and translational validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250013, China.
Förderung
- The Noncommunicable Chronic Diseases-National Science and Technology Major Project of China
- The Natural Science Foundation of Shandong Province
- Noncommunicable Chronic Diseases–National Science and Technology Major Project of the People’s Republic of China
- Natural Science Foundation of Shandong Province of China
Zitieren
APA
Zhang, S., Li, Y., Wang, Y., Guo, B., Liu, Z., & Liu, Z. (2026). The PVAT–MAMs Axis in Atherosclerosis: A Hypothesis-Driven Cross-Scale Conceptual Framework. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27072998
Vancouver
Zhang S, Li Y, Wang Y, Guo B, Liu Z, Liu Z. The PVAT–MAMs Axis in Atherosclerosis: A Hypothesis-Driven Cross-Scale Conceptual Framework. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27072998
BibTeX
@article{Zhang2026,
author = {Zhang, Sixiang and Li, Yuhan and Wang, Yingrui and Guo, Bingqi and Liu, Zixuan and Liu, Zheng},
title = {The PVAT–MAMs Axis in Atherosclerosis: A Hypothesis-Driven Cross-Scale Conceptual Framework},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27072998}
}
EUVIMED